| BMS-1166 HCl |
BMS-1166 HCl |
2113650-05-6 |
| TRC253 |
CS-2727 |
2110426-27-0 |
| AB 680) |
AB-680 |
2105904-82-1 |
| JNJ-63576253(TRC-253) |
化合物JNJ63576253 |
2110428-64-1 |
| GSK2894631A |
GSK-2894631A |
2101626-26-8 |
| S-GBOXIN |
S-GBOXIN |
2101317-21-7 |
| Ketohexokinase inhibitor 1 |
PF-06835919 |
2102501-84-6 |
| 8-Quinolinecarbonitrile, 5-[(3R,5S)-3-amino-5-(trifluoromethyl)-1-piperidinyl]- |
化合物ENPATORAN |
2101938-42-3 |
| 5-Thiazolecarboxamide, N-[(2S)-2-(4-chlorophenyl)-2-(4-morpholinyl)ethyl]-2-(2-pyrimidinyl)-4-(trifluoromethyl)- |
5-THIAZOLECARBOXAMIDE, N-[(2S)-2-(4-CHLOROPHENYL)-2-(4-MORPHOLINYL)ETHYL]-2-(2-PYRIMIDINYL)-4-(TRIF |
2097117-06-9 |
| GSK620 |
GSK620 |
2088410-46-0 |
| NAcM-OPT |
化合物NACM-OPT |
2089293-61-6 |
| Hexanoic acid, 3-methyl-6-[2-[[5-methyl-2-[4-(trifluoromethyl)phenyl]-1H-imidazol-1-yl]methyl]phenoxy]-, (3R)- |
化合物BOCIDELPAR |
2095128-20-2 |
| MA-0204 |
CS-2841 |
2095128-17-7 |
| GDC-0077 |
GDC-0077 |
2060571-02-8 |
| LAU159 |
LAU159 |
2055050-87-6 |
| MNK8 |
化合物MNK8 |
2055078-49-2 |
| 4-Thiazolecarboxamide, N-[3-(3,6-difluoro-2-pyridinyl)-1-(trans-4-ethoxycyclohexyl)-1H-pyrazol-4-yl]-2-(1H-pyrazol-4-yl)- |
4-Thiazolecarboxamide, N-[3-(3,6-difluoro-2-pyridinyl)-1-(trans-4-ethoxycyclohexyl)-1H-pyrazol-4-yl]-2-(1H-pyrazol-4-yl)- |
2033070-96-9 |
| 2-UNDECYL-THIAZOLIDINE-4-CARBOXYLIC ACID |
2-UNDECYL-THIAZOLIDINE-4-CARBOXYLIC ACID |
298186-80-8 |
| NPS 2143 |
2-氯-6-[(2R)-3-[[1,1-二甲基-2-(2-萘基)乙基]氨基]-2-羟基丙氧基]苯腈 |
284035-33-2 |
| AWZ1066S |
AWZ1066S |
2239272-16-1 |
QQ
微信
